{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T16:46:32Z","timestamp":1748969192267},"reference-count":53,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.43050","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T16:03:41Z","timestamp":1642003421000},"page":"e2143050","source":"Crossref","is-referenced-by-count":4,"title":["Association Between Prescription Opioid Therapy for Noncancer Pain and Hepatitis C Virus Seroconversion"],"prefix":"10.1001","volume":"5","author":[{"given":"James","family":"Wilton","sequence":"first","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Wong","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Purssell","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"Department of Emergency Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younathan","family":"Abdia","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Chong","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ehsanul","family":"Karim","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Centre for Health Evaluation & Outcome Sciences, St Paul's Hospital Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"MacInnes","sequence":"additional","affiliation":[{"name":"Pain Management Clinic, Jim Pattison Outpatient Care & Surgical Centre, Fraser Health Authority, Surrey, British Columbia, Canada"},{"name":"Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia R.","family":"Bartlett","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob F.","family":"Balshaw","sequence":"additional","affiliation":[{"name":"George and Fay Yee Centre for Healthcare Innovation, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara","family":"Gomes","sequence":"additional","affiliation":[{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada"},{"name":"Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada"},{"name":"ICES, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Yu","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Alvarez","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C.","family":"Dart","sequence":"additional","affiliation":[{"name":"Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, Colorado"},{"name":"Department of Emergency Medicine, University of Colorado Health Sciences Center, Denver"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mel","family":"Krajden","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane A.","family":"Buxton","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed Z.","family":"Janjua","sequence":"additional","affiliation":[{"name":"British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada"},{"name":"School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Centre for Health Evaluation & Outcome Sciences, St Paul's Hospital Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"issue":"1","key":"zoi211196r3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2105\/AJPH.2019.305379","article-title":"Prevalence of injecting drug use and coverage of interventions to prevent HIV and hepatitis C virus infection among people who inject drugs in Canada.","volume":"110","author":"Jack","year":"2020","journal-title":"Am J Public Health"},{"issue":"2","key":"zoi211196r4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014.","volume":"108","author":"Zibbell","year":"2018","journal-title":"Am J Public Health"},{"issue":"3","key":"zoi211196r5","article-title":"The opioid epidemic and national guidelines for opioid therapy for chronic noncancer pain: a perspective from different continents.","volume":"2","author":"H\u00e4user","year":"2017","journal-title":"Pain Rep"},{"issue":"4","key":"zoi211196r6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop.","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med"},{"issue":"23","key":"zoi211196r7","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1001\/jama.2018.18472","article-title":"Opioids for chronic noncancer pain: a systematic review and meta-analysis.","volume":"320","author":"Busse","year":"2018","journal-title":"JAMA"},{"issue":"4","key":"zoi211196r8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"issue":"3","key":"zoi211196r9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.36076\/ppj\/2019.22.229","article-title":"A systematic review of interventions and programs targeting appropriate prescribing of opioids.","volume":"22","author":"Moride","year":"2019","journal-title":"Pain Physician"},{"key":"zoi211196r10","article-title":"Prescription opioid therapy for non-cancer pain and initiation of injection drug use: large retrospective cohort study.","volume":"375","author":"Wilton","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"zoi211196r11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1155\/2013\/824914","article-title":"Nonmedical use of prescription opioids: what is the real problem?","volume":"18","author":"Lynch","year":"2013","journal-title":"Pain Res Manag"},{"issue":"2","key":"zoi211196r12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","article-title":"Relationship between nonmedical prescription-opioid use and heroin use.","volume":"374","author":"Compton","year":"2016","journal-title":"N Engl J Med"},{"issue":"9","key":"zoi211196r14","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1097\/j.pain.0000000000001606","article-title":"High-dose prescribed opioids are associated with increased risk of heroin use among United States military veterans.","volume":"160","author":"Banerjee","year":"2019","journal-title":"Pain"},{"issue":"2","key":"zoi211196r15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.drugpo.2013.10.004","article-title":"\u201cEvery \u2018never\u2019 I ever said came true\u201d: transitions from opioid pills to heroin injecting.","volume":"25","author":"Mars","year":"2014","journal-title":"Int J Drug Policy"},{"issue":"1","key":"zoi211196r16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.drugpo.2011.05.014","article-title":"Initiation into prescription opioid misuse amongst young injection drug users.","volume":"23","author":"Lankenau","year":"2012","journal-title":"Int J Drug Policy"},{"key":"zoi211196r17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.drugpo.2017.03.003","article-title":"Down in the valley: trajectories of injection initiation among young injectors in California\u2019s Central Valley.","volume":"44","author":"Syvertsen","year":"2017","journal-title":"Int J Drug Policy"},{"key":"zoi211196r18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108256","article-title":"Opioid initiation and injection transition in rural northern New England: a mixed-methods approach.","volume":"217","author":"Nolte","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi211196r19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jsat.2014.07.002","article-title":"Injection and sexual HIV\/HCV risk behaviors associated with nonmedical use of prescription opioids among young adults in New York City.","volume":"48","author":"Mateu-Gelabert","year":"2015","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"zoi211196r20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/pm\/pny228","article-title":"International stakeholder community of pain experts and leaders call for an urgent action on forced opioid tapering.","volume":"20","author":"Darnall","year":"2019","journal-title":"Pain Med"},{"issue":"2","key":"zoi211196r21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1377\/hlthaff.2018.05232","article-title":"A transitioning epidemic: how the opioid crisis is driving the rise in hepatitis C.","volume":"38","author":"Powell","year":"2019","journal-title":"Health Aff (Millwood)"},{"key":"zoi211196r22","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/cid\/cis393","article-title":"Evolving epidemiology of hepatitis C virus in the United States.","volume":"55","author":"Klevens","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"zoi211196r23","doi-asserted-by":"publisher","first-page":"816","DOI":"10.2105\/AJPH.2013.301812","article-title":"Confronting the emerging epidemic of HCV infection among young injection drug users.","volume":"104","author":"Valdiserri","year":"2014","journal-title":"Am J Public Health"},{"issue":"42","key":"zoi211196r24","first-page":"1457","article-title":"Notes from the field: risk factors for hepatitis C virus infections among young adults\u2014Massachusetts, 2010.","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"zoi211196r25","doi-asserted-by":"publisher","first-page":"10521","DOI":"10.1038\/s41598-020-67013-6","article-title":"Finding undiagnosed patients with hepatitis C infection: an application of artificial intelligence to patient claims data.","volume":"10","author":"Doyle","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"zoi211196r26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/ADM.0000000000000702","article-title":"Identification of risk factors for testing of hepatitis C in non-birth cohort patients: is universal screening necessary?","volume":"15","author":"Smart","year":"2021","journal-title":"J Addict Med"},{"issue":"7","key":"zoi211196r27","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/add.2012.107.issue-7","article-title":"The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users.","volume":"107","author":"Bruneau","year":"2012","journal-title":"Addiction"},{"issue":"7","key":"zoi211196r28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005419","article-title":"Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youth.","volume":"4","author":"Hadland","year":"2014","journal-title":"BMJ Open"},{"issue":"3","key":"zoi211196r29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150176","article-title":"Assessing hepatitis C burden and treatment effectiveness through the British Columbia hepatitis testers cohort (BC-HTC): design and characteristics of linked and unlinked participants.","volume":"11","author":"Janjua","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"zoi211196r30","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.2105\/AJPH.2015.302591","article-title":"Decreasing hepatitis C incidence among a population with repeated tests: British Columbia, Canada, 1993-2011.","volume":"105","author":"Kuo","year":"2015","journal-title":"Am J Public Health"},{"key":"zoi211196r31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.drugpo.2018.02.001","article-title":"Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets.","volume":"55","author":"Janjua","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"1","key":"zoi211196r32","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/ije\/dyx134","article-title":"Incidence rate estimation, periodic testing and the limitations of the mid-point imputation approach.","volume":"47","author":"Vandormael","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"6","key":"zoi211196r33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","article-title":"De facto long-term opioid therapy for noncancer pain.","volume":"24","author":"Von Korff","year":"2008","journal-title":"Clin J Pain"},{"issue":"4","key":"zoi211196r34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043586","article-title":"Cohort profile: development and characteristics of a retrospective cohort of individuals dispensed prescription opioids for non-cancer pain in British Columbia, Canada.","volume":"11","author":"Wilton","year":"2021","journal-title":"BMJ Open"},{"key":"zoi211196r35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.drugalcdep.2018.09.019","article-title":"Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015-2016.","volume":"194","author":"Smolina","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"18","key":"zoi211196r36","doi-asserted-by":"publisher","first-page":"E659","DOI":"10.1503\/cmaj.170363","article-title":"Guideline for opioid therapy and chronic noncancer pain.","volume":"189","author":"Busse","year":"2017","journal-title":"CMAJ"},{"issue":"15","key":"zoi211196r37","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016.","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"10179","key":"zoi211196r38","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.","volume":"393","author":"Carrat","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"zoi211196r40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.j.pain.0000460303.63948.8e","article-title":"The Pain and Opioids in Treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain.","volume":"156","author":"Campbell","year":"2015","journal-title":"Pain"},{"key":"zoi211196r41","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.addbeh.2016.08.016","article-title":"Prescription opioids prior to injection drug use: comparisons and public health implications.","volume":"65","author":"Al-Tayyib","year":"2017","journal-title":"Addict Behav"},{"issue":"2","key":"zoi211196r42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/dar.2015.34.issue-2","article-title":"Denial of prescription analgesia among people who inject drugs in a Canadian setting.","volume":"34","author":"Voon","year":"2015","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"zoi211196r43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13011-017-0112-7","article-title":"Physical pain is common and associated with nonmedical prescription opioid use among people who inject drugs.","volume":"12","author":"Dahlman","year":"2017","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"1","key":"zoi211196r44","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jpainsymman.2007.08.013","article-title":"Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C.","volume":"36","author":"Whitehead","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"zoi211196r45","doi-asserted-by":"crossref","DOI":"10.1177\/21501327211034379","article-title":"Oral prescription opioids as a high-risk indicator for hepatitis C infection: another step toward HCV elimination.","volume":"12","author":"Hack","year":"2021","journal-title":"J Prim Care Community Health"},{"issue":"1","key":"zoi211196r47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/infdis\/jir196","article-title":"A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.","volume":"204","author":"Hagan","year":"2011","journal-title":"J Infect Dis"},{"issue":"1","key":"zoi211196r48","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12889-016-3136-4","article-title":"Peer engagement in harm reduction strategies and services: a critical case study and evaluation framework from British Columbia, Canada.","volume":"16","author":"Greer","year":"2016","journal-title":"BMC Public Health"},{"issue":"34","key":"zoi211196r49","doi-asserted-by":"publisher","first-page":"E986","DOI":"10.1503\/cmaj.201618","article-title":"A safer drug supply: a pragmatic and ethical response to the overdose crisis.","volume":"192","author":"Tyndall","year":"2020","journal-title":"CMAJ"},{"issue":"11","key":"zoi211196r51","doi-asserted-by":"publisher","first-page":"e928","DOI":"10.1016\/j.ijid.2010.03.019","article-title":"Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis.","volume":"14","author":"Jafari","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"3","key":"zoi211196r52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/OLQ.0000000000000250","article-title":"Sexually transmitted infection trends among gay or bisexual men from a clinic-based sentinel surveillance system in British Columbia, Canada.","volume":"42","author":"Ling","year":"2015","journal-title":"Sex Transm Dis"},{"issue":"7","key":"zoi211196r53","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/17425255.2019.1634053","article-title":"Opioids and the risk of infection: a critical appraisal of the pharmacologic and clinical evidence.","volume":"15","author":"Khosrow-Khavar","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"zoi211196r39","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"Grambsch","year":"2000"},{"key":"zoi211196r1","unstructured":"United States Centers for Disease Control and Prevention. Viral hepatitis surveillance, United States, 2017. November 14, 2019. Accessed July 22, 2021. https:\/\/www.cdc.gov\/hepatitis\/statistics\/2017surveillance\/pdfs\/2017HepSurveillanceRpt.pdf"},{"key":"zoi211196r2","unstructured":"Public Health Agency of Canada. Report on hepatitis B and C in Canada: 2016. April 5, 2019. Accessed July 22, 2021. https:\/\/www.canada.ca\/en\/services\/health\/publications\/diseases-conditions\/report-hepatitis-b-c-canada-2016.html"},{"key":"zoi211196r13","unstructured":"Muhuri? P, Gfroerer? M, Davies? C. Associations of nonmedical pain reliever use and initiation of heroin use in the United States. August 2013. Accessed July 22, 2021. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/DR006\/DR006\/nonmedical-pain-reliever-use-2013.htm"},{"key":"zoi211196r46","unstructured":"Canadian Pain Task Force. Chronic pain in Canada: laying a foundation for action. June 2019. Accessed July 22, 2021. https:\/\/www.canada.ca\/content\/dam\/hc-sc\/documents\/corporate\/about-health-canada\/public-engagement\/external-advisory-bodies\/canadian-pain-task-force\/report-2019\/canadian-pain-task-force-June-2019-report-en.pdf"},{"key":"zoi211196r50","unstructured":"BC Centre for Disease Control. Reportable diseases data dashboard. Accessed July 22, 2021. http:\/\/www.bccdc.ca\/health-professionals\/data-reports\/reportable-diseases-data-dashboard"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2787978\/wilton_2022_oi_211196_1641393915.82611.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T16:03:54Z","timestamp":1642003434000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2787978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.43050","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,12]]}}}